glutathione kills triple negative cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the redox-programmed cell death
Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery The crosstalk between glutathione metabolism and non coding RNAs in cancer progression and treatment resistance ScienceDirect A photodynamic mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy ScienceDirect Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



